NRx Pharmaceuticals, Inc. (NASDAQ: NRXP), a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system (CNS) disorders, ...

Iver Anderson, senior metallurgist at the U.S. Department of Energy's Ames Laboratory and adjunct professor in the Materials Science and Engineering Department at Iowa State University, has been ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces its financial results for the year ended ...

Collaboration strengthens AZL's ability to design custom, integrated supply chain solutions for complex shipper ...

The global medical cyclotron market shows steady growth, expected to be valued at around US$246.8 million in 2026 and projected to reach US$405.4 million by 2033, with a CAGR of 5.4% during this ...

Marksman provides cross-border freight agency services supporting shipments between the United States and Mexico with a focus on coordinating international transportation, carrier sourcing, and ...

Intimate NYC forum where longevity pioneers, clinicians, and investors connect directly to accelerate the lab-to-clinic ...

Nexstim’s Therapy Business markets and sells the NBS System 6 which is FDA-cleared for marketing and commercial distribution for the treatment of major depressive disorder (MDD) in the United States.

Beyond deterring theft, the new trailer technology helps protect sensitive, at-risk freight. In addition, it uses computer vision to automatically document trailer activity ...

The global medical cyclotron market shows steady growth, expected to be valued at around US$246.8 million in 2026 and projected to reach US$405.4 million ...

Nexstim Receives Clearance for its NBS 6 Diagnostics System in UAE Nexstim Plc ("Nexstim" or "Company") has received import clearance for its ...

Streamlines supplier collaboration and operations from source to ship WiseTech Global (ASX:WTC)The platform is ...